SecBot SecBot

RDAC

Rising Dragon Acquisition Corp.
Nasdaq· Blank Checks· CIK 0002018145 Traditional Finance
$5.03 +0.13 (+2.65%)
Oct 26 4:00 PM ET · prev $4.90
1 year
−51.9%
from $10.46 · Oct 27
30 days
−5.5%
from $5.32
52-week range
$4.56–20.51
−75% from high · low Aug 31
Avg volume 20D
9.9K
shares / day
Short interest
33.3K
−45.6%
Days to cover
1.6
at average volume
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
2
analyzed by SecBot
SecBot read BEARISH 2 reports · 90 days
Balance 1 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 2/2
Strongest BEARISH Rising Dragon Acquisition Corp. (RDAC) received a Nasdaq delisting notice on August 19, 2026, because its…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 0 added (0 new), 1 trimmed or exited.

  • Short sellersCOVERING

    Short interest −45.6% to 33.3K shares. 1.6 days to cover.

  • TrendDOWNTREND

    10% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
Clear Street Group Inc.TRIM22,305$232.9K

Quarterly 13F filings are due 45 days after each quarter ends.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 13, 2026 SEC
Rising Dragon Acquisition Corp. issued two unsecured promissory notes totaling $111,274.82 to SZG Limited (designee of…
8-K — Impact 3/10
Sep 1, 2026 Trading halt
Halt Resumed: RDAC — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-09-01T14:11:46.000Z | Resumed 2026-09-01T14:16:46.000Z
Aug 20, 2026 SEC
Rising Dragon Acquisition Corp. (RDAC) received a Nasdaq delisting notice on August 19, 2026, because its Market Value…
8-K — Impact 7/10
Jul 29, 2026 Event
Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Laboratories, Inc., Brockton, MA. NDC 64980-504-48.
Class II: Presence of Precipitate: medication was crystallizing and particles floating in the bottle
Jun 30, 2026 Inst.
Clear Street Group Inc. — TRIM
22,305 shares ($232.9K)

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Sep 30, 2026
33,308
shares short
-45.6%
vs prior settlement
1.6
days to cover
Trading halts
Sep 1, 2026Volatility PauseResumed
Aug 24, 2026Volatility PauseResumed
Aug 19, 2026Volatility PauseResumed
Aug 19, 2026Volatility PauseResumed
Aug 19, 2026Volatility PauseResumed
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 1, 2026
Trading halt
Halt Resumed: RDAC — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-09-01T14:11:46.000Z | Resumed 2026-09-01T14:16:46.000Z
Sep 1, 2026
Trading halt
Trading Halt: RDAC — LUDP (Volatility Trading Pause)
Rising Dragon Acq Cp Ord | Market: NASDAQ | Code: LUDP — Volatility Trading Pause
Aug 26, 2026
Listing
Listing Status: RDAC — Deficient (was Normal)
Rising Dragon Acquisition Corp. - Ordinary Shares | Nasdaq Financial Status Indicator N → D
Aug 24, 2026
Trading halt
Halt Resumed: RDAC — trading resumed after LUDP (Volatility Trading Pause)
Halted 2026-08-24T13:53:06.000Z | Resumed 2026-08-24T13:58:06.000Z
Aug 24, 2026
Trading halt
Trading Halt: RDAC — LUDP (Volatility Trading Pause)
Rising Dragon Acq Cp Ord | Market: NASDAQ | Code: LUDP — Volatility Trading Pause

SecBot reports

2 filings · 0 bullish · 1 bearish · 1 neutral
All RDAC filing & press-release reports (2)